Home/Cases/Setterwalls has assisted Recipharm in connection with directed share issue of ap... case / 25 Jun 2018Share / Setterwalls has assisted Recipharm in connection with directed share issue of approximately SEK 508 million Setterwalls has assisted Recipharm AB (publ) in connection with a directed share issue to a number of Swedish and international institutional investors. The gross proceeds of the share issue amounts to approximately SEK 508 million. Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing around 5,000 employees. For further information about the share issue and Recipharm, please refer to the company’s website. Contact: Jörgen S. Axelsson, Axel Helle Practice areas: Equity Capital Markets, Life Sciences Back Next article